title: Patient HIV-1 strains carrying the multiple nucleoside resistance mutations are cross-resistant to abacavir.
authors.forename: K
authors.initials: K
authors.lastname: Van Laethem
authors.forename: M
authors.initials: M
authors.lastname: Witvrouw
authors.forename: J
authors.initials: J
authors.lastname: Balzarini
authors.forename: J C
authors.initials: JC
authors.lastname: Schmit
authors.forename: S
authors.initials: S
authors.lastname: Sprecher
authors.forename: P
authors.initials: P
authors.lastname: Hermans
authors.forename: M
authors.initials: M
authors.lastname: Leal
authors.forename: T
authors.initials: T
authors.lastname: Harrer
authors.forename: L
authors.initials: L
authors.lastname: Ruiz
authors.forename: B
authors.initials: B
authors.lastname: Clotet
authors.forename: M
authors.initials: M
authors.lastname: Van Ranst
authors.forename: J
authors.initials: J
authors.lastname: Desmyter
authors.forename: E
authors.initials: E
authors.lastname: De Clercq
authors.forename: A M
authors.initials: AM
authors.lastname: Vandamme
mesh_terms: D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D015224:Dideoxynucleosides / Q000494:pharmacology*; D004352:Drug Resistance, Microbial / Q000235:genetics*; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy / Q000821:virology*; D015497:HIV-1 / Q000187:drug effects* / Q000235:genetics; D006801:Humans; D009154:Mutation; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D000099227:Abacavir
chemical_list: D019380:Anti-HIV Agents; D015224:Dideoxynucleosides; D018894:Reverse Transcriptase Inhibitors; D000099227:Abacavir